Drug prices : effects of opening federal supply schedule for pharmaceuticals are uncertain : report to Congressional committees and the Administrator of General Services /

Drug control : reauthorization of the Office of National Drug Control Policy : report to the Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Government Operations.

"B-254530"--P. [1]."GAO/GGD-93-144.""September 1993."Cover title.Includes bibliographical references...

Drug control : status report on counterdrug technology development : report to Congressional requesters /

United States. General Accounting Office.

Cover title."B-242554"--P. 1."GAO/NSIAD-93-104.""January 1993."Mode of access: Internet

Skyrocketing prescription drug prices : turning a bad deal into a fair deal : a majority staff report of the Special Committee on Aging, United States Senate.

United States. Congress. Senate. Special Committee on Aging.

January 1990

"Serial no. 101-F"."January 1990".At head of title: 101st Congress, 2d session. Committee print.Mode...

Prescription drugs : changes in prices for selected drugs : report to Congressional requesters /

United States. General Accounting Office.

"B-249510"--P. 1."GAO/HRD-92-128."Cover title."August 1992."Includes bibliographical references.Mode...

Adverse drug events : the magnitude of health risk is uncertain because of limited incidence data : report to Congressional requesters /

United States. General Accounting Office.

"B-281822"--P. 1."GAO/HEHS-00-21.""January 2000."Cover title.Includes bibliographical references (p....

Prescription drug prices : official index overstates producer price inflation : report to the Chairman, Special Committee on Aging, U.S. Senate /

United States. General Accounting Office.
United States. Congress. Senate. Special Committee on Aging.

"B-260293"--P. 1."GAO/HEHS-95-90.""April 1995."Cover title.Includes bibliographical references (p. 2...

Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

Jaggar, Sarah F.
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
United States. General Accounting Office.

"September 19, 1996."Cover title.Includes bibliographical references (p. 8).Mode of access: Internet

Medicare : effect of durable medical equipment fee schedules on six suppliers' profits : report to Congressional committees /

United States. General Accounting Office.

"B-245845"--P. 1."GAO/HRD-92-22.""November 1991."Cover title.Includes bibliographical references.Mod...

Prescription drugs : price trends for frequently used brand and generic drugs from 2000 through 2004: report to congressional requesters /

United States. Government Accountability Office.
Kanoff, Marjorie.

"GAO-05-779.""August 2005."Cover title.Includes bibliographical references.Letter -- Appendix I, Sco...

Medicaid : changes in drug prices paid by HMOs and hospitals since enactment of rebate provisions : report to Congressional committees /

United States. General Accounting Office.

"January 1993.""B-245873"--P. 1."GAO/HRD-93-43."Cover title.Includes bibliographical references.Mode...

Medicaid : changes in drug prices paid by VA and DOD since enactment of rebate provisions : report to congressional committees /

United States. General Accounting Office.

"B-245667"--p.1."GAO/HRD-91-139""September 1991"Cover title.Mode of access: Internet

Prescription drug prices : analysis of Canada's Patented Medicine Prices Review Board : report to the Chairman, Special Committee on Aging, U.S. Senate /

United States. General Accounting Office.
United States. Congress. Senate. Special Committee on Aging.

"GAO/HRD-93-51.""B-247942"--P. 1."February 1993."Cover title.Includes bibliographical references.Mod...

Perspectives on pharmaceutical pricing practices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

January 1996

"Serial no. 104-113."Shipping list no.: 97-0072-P.Distributed to some depository libraries in microf...

Recent developments which may impact consumer access to, and demand for, pharmaceuticals : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 13, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2001

"Serial no. 107-34."Shipping list no.: 2002-0017-P.Distributed to depository libraries in microfiche...

FDA drug approval : review time has decreased in recent years : report to Congressional requesters /

United States. General Accounting Office.

"B-266023"--P. 1."GAO/PEMD-96-1.""October 1995."Cover title.Includes bibliographical references.Mode...

Drug control : reauthorization of the Office of National Drug Control Policy : report to the Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Government Operations.

"B-254530"--P. [1]."GAO/GGD-93-144.""September 1993."Cover title.Includes bibliographical references...

Drug control : status report on counterdrug technology development : report to Congressional requesters /

United States. General Accounting Office.

Cover title."B-242554"--P. 1."GAO/NSIAD-93-104.""January 1993."Mode of access: Internet

Skyrocketing prescription drug prices : turning a bad deal into a fair deal : a majority staff report of the Special Committee on Aging, United States Senate.

United States. Congress. Senate. Special Committee on Aging.

January 1990

"Serial no. 101-F"."January 1990".At head of title: 101st Congress, 2d session. Committee print.Mode...

Prescription drugs : changes in prices for selected drugs : report to Congressional requesters /

United States. General Accounting Office.

"B-249510"--P. 1."GAO/HRD-92-128."Cover title."August 1992."Includes bibliographical references.Mode...

Adverse drug events : the magnitude of health risk is uncertain because of limited incidence data : report to Congressional requesters /

United States. General Accounting Office.

"B-281822"--P. 1."GAO/HEHS-00-21.""January 2000."Cover title.Includes bibliographical references (p....

Prescription drug prices : official index overstates producer price inflation : report to the Chairman, Special Committee on Aging, U.S. Senate /

United States. General Accounting Office.
United States. Congress. Senate. Special Committee on Aging.

"B-260293"--P. 1."GAO/HEHS-95-90.""April 1995."Cover title.Includes bibliographical references (p. 2...

Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

Jaggar, Sarah F.
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
United States. General Accounting Office.

"September 19, 1996."Cover title.Includes bibliographical references (p. 8).Mode of access: Internet

Medicare : effect of durable medical equipment fee schedules on six suppliers' profits : report to Congressional committees /

United States. General Accounting Office.

"B-245845"--P. 1."GAO/HRD-92-22.""November 1991."Cover title.Includes bibliographical references.Mod...

Prescription drugs : price trends for frequently used brand and generic drugs from 2000 through 2004: report to congressional requesters /

United States. Government Accountability Office.
Kanoff, Marjorie.

"GAO-05-779.""August 2005."Cover title.Includes bibliographical references.Letter -- Appendix I, Sco...

Medicaid : changes in drug prices paid by HMOs and hospitals since enactment of rebate provisions : report to Congressional committees /

United States. General Accounting Office.

"January 1993.""B-245873"--P. 1."GAO/HRD-93-43."Cover title.Includes bibliographical references.Mode...

Medicaid : changes in drug prices paid by VA and DOD since enactment of rebate provisions : report to congressional committees /

United States. General Accounting Office.

"B-245667"--p.1."GAO/HRD-91-139""September 1991"Cover title.Mode of access: Internet

Prescription drug prices : analysis of Canada's Patented Medicine Prices Review Board : report to the Chairman, Special Committee on Aging, U.S. Senate /

United States. General Accounting Office.
United States. Congress. Senate. Special Committee on Aging.

"GAO/HRD-93-51.""B-247942"--P. 1."February 1993."Cover title.Includes bibliographical references.Mod...

Perspectives on pharmaceutical pricing practices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

January 1996

"Serial no. 104-113."Shipping list no.: 97-0072-P.Distributed to some depository libraries in microf...

Recent developments which may impact consumer access to, and demand for, pharmaceuticals : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 13, 2001.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.

January 2001

"Serial no. 107-34."Shipping list no.: 2002-0017-P.Distributed to depository libraries in microfiche...

FDA drug approval : review time has decreased in recent years : report to Congressional requesters /

United States. General Accounting Office.

"B-266023"--P. 1."GAO/PEMD-96-1.""October 1995."Cover title.Includes bibliographical references.Mode...

Drug control : reauthorization of the Office of National Drug Control Policy : report to the Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Government Operations.

"B-254530"--P. [1]."GAO/GGD-93-144.""September 1993."Cover title.Includes bibliographical references...

Drug control : status report on counterdrug technology development : report to Congressional requesters /

United States. General Accounting Office.

Cover title."B-242554"--P. 1."GAO/NSIAD-93-104.""January 1993."Mode of access: Internet

Skyrocketing prescription drug prices : turning a bad deal into a fair deal : a majority staff report of the Special Committee on Aging, United States Senate.

United States. Congress. Senate. Special Committee on Aging.

January 1990

"Serial no. 101-F"."January 1990".At head of title: 101st Congress, 2d session. Committee print.Mode...

Drug prices : effects of opening federal supply schedule for pharmaceuticals are uncertain : report to Congressional committees and the Administrator of General Services /

Abstract

Extracted data

Drug prices : effects of opening federal supply schedule for pharmaceuticals are uncertain : report to Congressional committees and the Administrator of General Services /

Abstract

Extracted data

Related items

Related items